Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.85M Buy
147,900
+109,200
+282% +$3.31M ﹤0.01% 2382
2026
Q1
$1.08M Buy
38,700
+25,800
+200% +$657K ﹤0.01% 3202
2025
Q4
$253K Buy
+12,900
New +$272K ﹤0.01% 3902
2025
Q2
Sell
-18,100
Closed -$298K 3602
2025
Q1
$298K Buy
18,100
+1,100
+6% +$21.3K ﹤0.01% 2930
2024
Q4
$331K Sell
17,000
-1,300
-7% -$31.7K ﹤0.01% 2949
2024
Q3
$626K Buy
+18,300
New +$671K ﹤0.01% 2295

Other funds holding TRMD

IMC Chicago's TRMD Position: Q2 2026 in Review

IMC Chicago increased its TORM (TRMD) stake by 40% in Q2 2026, buying an estimated $218K and bringing the position to 25,275 shares worth $659K. The position accounts for ﹤0.01% of the portfolio, ranked #4327.

IMC Chicago first reported a position in TRMD in Q3 2024 and has held it in 4 quarters since. 152 funds tracked by Wall St. Rank hold TRMD as of Q2 2026.

  • IMC Chicago held 25,275 shares of TORM worth $659K as of Q2 2026.
  • IMC Chicago bought 7,196 TORM shares in Q2 2026, an estimated $218K.
  • TORM made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #4327 holding.
  • IMC Chicago first reported a position in TORM in Q3 2024 and has held it in 4 quarters since.
  • 152 funds tracked by Wall St. Rank held TORM as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.